Facebook Linkedin Twitter
Home Topics Molecular Dx Page 264

Molecular Dx

Incidental findings occur in clinical
Molecular Dx

Unexpected Findings Anything but “Incidental”

Alex Philippidis
0
Appistry's CSO Richard Mazzarella
Molecular Dx

VIEW NOW—Clinically Actionable Genomics: From Sequencing to Personalized Medicine

0
Clinical OMICs Magazine: Volume 5
Molecular Dx

The Promise of Panomics: Decoding Biological Networks to Identify Pathways Involved in Complex Diseases

Szilard Voros, M.D.
0
Clinical OMICs Magazine: Volume 5
Molecular Dx

Medically, Proteomics Advances Will Rival the Genetics Advances of the Last Ten Years

Mitzi Perdue
0
Clinical OMICs Magazine: Volume 5
Molecular Dx

Counselors Face a Balancing Act as Challenges Loom

Alex Philippidis
0
Clinical OMICs Magazine: Volume 5
Molecular Dx

Driving Mass Spec-Based Multiplexed Protein Biomarker Tests to the Clinic

Vicki Glaser
0
Clinical OMICs Magazine: Volume 4
Molecular Dx

NGS and Cancer Biomarker Market Metrics

Enal Razvi, Ph.D. and Gary M. Oosta, Ph.D.
0
Clinical OMICs Magazine: Volume 4
Molecular Dx

CGI to Perform Cancer Dx Testing in Central America, Caribbean for AstraZeneca

0
Clinical OMICs Magazine: Volume 4
Molecular Dx

PerkinElmer Launches Newborn Screening Program in China

0
Clinical OMICs Magazine: Volume 4
Molecular Dx

Mass Spectrometry: Transition from Research to Clinic

Enal Razvi, Ph.D.
0
1...263264265266Page 264 of 266

Related Content

Sage Publishing

Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.
Terms of ServicePrivacy Policy

Sage Publishing
Inside Precision Medicine